Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.94 USD | +3.00% |
|
+2.74% | +19.33% |
22/05 | Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing | MT |
14/05 | Transcript : Vaxcyte, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.33% | 815.31Cr | |
+15.19% | 12TCr | |
+19.91% | 11TCr | |
+8.24% | 2.36TCr | |
-19.80% | 2.04TCr | |
-16.19% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- Vaxcyte Insider Sold Shares Worth $599,909, According to a Recent SEC Filing